Clinical Trial Update: S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update examining anastrozole with or without fulvestrant as first-line therapy in postmenopausal women with metastatic breast cancer has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-04-04